Measles — the Canary in the Coal Mine

Since January 2026 Bangladesh has experienced a sharp rise in measles cases. On 4 April 2026 the National IHR Focal Point notified WHO of a nationwide increase affecting 58 of 64 districts, indicating widespread transmission. As of 1 May 2026, reported measles cases exceeded 38,000 and deaths with measles-like symptoms totaled 231.

Most cases are among children under five years, including some infants younger than six months. Because of ongoing transmission across multiple divisions, large numbers of susceptible children, documented immunity gaps, and suspected measles-related deaths, WHO assessed the national risk as Grade 2, requiring immediate and substantial intervention with regional and global support.

On 30 March 2026 the National Immunization Technical Advisory Group approved an emergency measles-rubella vaccination response. Emergency MR campaigns for children aged 6 to 59 months began on 5 April, initially targeting about 1.2 million children in 30 upazilas across 18 priority districts.

A nationwide MR campaign expanded from 20 April, accompanied by intensified surveillance, district rapid response teams, case isolation, strengthened hospital preparedness, and mass public-awareness activities. According to national and UNICEF reporting, more than 11.35 million children had already been reached under the emergency campaign by the end of April 2026.

The outbreak reflects multiple causes but is driven predominantly by suboptimal population immunity. Many cases occurred among children who were unvaccinated or had received only one dose of a measles-containing vaccine. Some infants were infected before the routine eligibility age of nine months.

Ninety-one percent of cases have been reported among children aged 1 to 14 years, indicating major immunity gaps in that cohort, and 34 percent of cases were in children below the routine MR eligibility age. That pattern has already triggered early vaccination in emergency settings and prompted discussion about an earlier measles dose in the routine program.

Bangladesh had made strong progress toward measles elimination in line with the WHO South-East Asia regional goal, with improving two-dose coverage and falling incidence. Several setbacks, however, reversed that progress. Routine EPI sessions were disrupted during the COVID-19 pandemic, and the EPI Coverage Evaluation Survey 2023 showed MR1 coverage at 92.9 percent and MR2 at 80.7 percent, both below the at least 95 percent threshold required for herd immunity.

Repeated health-worker strikes, chronic staff shortages, procurement and operational delays, the absence of nationwide supplementary campaigns since 2021, and fewer vitamin A rounds increased the pool of susceptible children. Declines in breastfeeding and broader social determinants also contributed to the widening immunity gaps.

Measles is highly contagious and remains a leading cause of childhood death worldwide. A single measles case can produce 15 to 18 secondary infections. Complications are more frequent and severe in malnourished children and those with vitamin A deficiency or weakened immunity. These complications include diarrhea, pneumonia, hearing loss, blindness, encephalitis, and death.

Measles also causes immune amnesia, increasing long-term susceptibility to other infections. The most severe long-term complication is subacute sclerosing panencephalitis, a rare, progressive, and usually fatal neurodegenerative disease that typically appears years after acute infection.

In some communities, caregivers still do not perceive measles as serious. They may withhold protein foods from sick children or delay seeking care until complications develop, which worsens outcomes.

Because measles remains endemic in the WHO South-East Asia Region, cross-border spread is a real risk. Bangladesh's borders with India and Myanmar and ongoing population mobility may facilitate continued transmission. Myanmar is particularly vulnerable because of large numbers of unvaccinated children and limited surveillance and response capacity amid humanitarian crises, while India and Nepal have also reported rising case counts in recent months.

Measles is therefore a sentinel - a canary in the coal mine - for deeper system weaknesses. Just as miners once used canaries to detect toxic gases before people were harmed, rising measles cases expose hidden weaknesses in immunization, supply chains, routine services, and the broader health system. When measles resurges, it often signals that other vaccine-preventable diseases may follow.

WHO warns that continued spread is likely unless urgent measures are taken to strengthen surveillance, rapidly detect and respond to cases, and close immunity gaps through high-quality vaccination. Priority actions include:

• Achieve and sustain at least 95 percent two-dose MR coverage through routine EPI in every district each year.
• Conduct targeted supplementary immunization activities where immunity gaps are identified.
• Maintain strong surveillance, timely case detection and reporting, and rapid response capacity.
• Ensure vaccine availability and robust supply-chain management.
• Continue vitamin A supplementation and deworming as scheduled.
• Promote exclusive breastfeeding and address social determinants that increase vulnerability.
• Educate and engage communities to improve risk perception and care-seeking.

With coordinated action by the Ministry of Health, development partners, and communities, and with restored high-quality vaccination coverage, Bangladesh can expect the outbreak to decline and resume progress toward measles elimination. Continued vigilance is essential to ensure no child is left unvaccinated against measles or any other vaccine-preventable disease.